PMC:7319919 / 6691-7025
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T40 | 203-211 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T68 | 86-87 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T52 | 153-172 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T53 | 153-162 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T54 | 163-172 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T55 | 174-182 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 167 | 212-220 | Species | denotes | patients | Tax:9606 |
| 168 | 153-172 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 169 | 174-182 | Chemical | denotes | imatinib | MESH:D000068877 |
| 170 | 188-199 | Chemical | denotes | baricitinib | MESH:C000596027 |
| 171 | 203-211 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T51 | 0-33 | Sentence | denotes | Declaration of Competing Interest |
| T52 | 34-221 | Sentence | denotes | David Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib, and baricitinib in COVID-19 patients. |
| T53 | 222-284 | Sentence | denotes | The rest of the authors are sub-investigators in this project. |
| T54 | 285-334 | Sentence | denotes | All authors declare no other competing interests. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T94 | 153-162 | DG_23 | denotes | lopinavir |
| T95 | 163-172 | DG_30 | denotes | ritonavir |
| T96 | 174-182 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
| T97 | 188-199 | DG_41 | denotes | baricitinib |
| T98 | 203-211 | SP_7 | denotes | COVID-19 |
| T99569 | 153-162 | DG_23 | denotes | lopinavir |
| T38180 | 163-172 | DG_30 | denotes | ritonavir |
| T67623 | 174-182 | CHEBI:14434;CHEBI:14434 | denotes | imatinib |
| T63693 | 188-199 | DG_41 | denotes | baricitinib |
| T80737 | 203-211 | SP_7 | denotes | COVID-19 |